Autolus Therapeutics plc Quarterly Debt-to-equity in % from Q1 2020 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Autolus Therapeutics plc quarterly Debt-to-equity history and growth rate from Q1 2020 to Q2 2024.
Autolus Therapeutics plc Debt-to-equity for the quarter ending June 30, 2024 was 80.9 %, a 9.16% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	80.9	+6.79	+9.16%	Jun 30, 2024
Q1 2024	93.4	+31.1	+49.8%	Mar 31, 2024
Q4 2023	115	+63.3	+123%	Dec 31, 2023
Q3 2023	85.3	+45	+111%	Sep 30, 2023
Q2 2023	74.2			Jun 30, 2023
Q1 2023	62.3			Mar 31, 2023
Q4 2022	51.5			Dec 31, 2022
Q3 2022	40.3			Sep 30, 2022
Q1 2021	26.5	+9.21	+53.3%	Mar 31, 2021
Q4 2020	26.8			Dec 31, 2020
Q3 2020	22.2			Sep 30, 2020
Q2 2020	18.3			Jun 30, 2020
Q1 2020	17.3			Mar 31, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.